# Cardinal Health, Inc. (CAH) FY2025 YTD Q3 P&L / Income Statement

- Company: Cardinal Health, Inc. (CAH)
- Period: 2024-07-01 to 2025-03-31
- Filing: Q3 FY2025 10-Q, filed 2025-05-01, accession number 0000721371-25-000038
- Page: https://plicit.ai/financials/cah/fy2025-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/cah-fy2025-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2024-07-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 162,419,000,000 US dollars
- **Cost of products sold**: 156,453,000,000 US dollars
- **Gross margin**: 5,966,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 4,119,000,000 US dollars
- **Operating earnings**: 1,847,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 130,000,000 US dollars
- **Earnings/(loss) before income taxes**: 1,717,000,000 US dollars
- **Provision for income taxes**: 391,000,000 US dollars
- **Net earnings/(loss)**: 1,326,000,000 US dollars
- **Pharmaceutical and Specialty Solutions**: 149,272,000,000 US dollars
- **Global Medical Products and Distribution**: 9,437,000,000 US dollars
- **Other Segments**: 3,773,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 3,898,000,000 US dollars
- **Restructuring and employee severance**: 61,000,000 US dollars
- **Amortization and other acquisition-related costs**: 331,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 20,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: negative 15,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 176,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 162,482,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Corporate**: negative 63,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmaceutical and Specialty Solutions costs (calculated)**: 147,549,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Global Medical Products and Distribution costs (calculated)**: 9,372,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Other Segments costs (calculated)**: 3,417,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 234,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.32 B; to noncontrolling interests: $4.00 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/cah/fy2025-ytd-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/cah-fy2025-ytd-q3-revenue-by-geography-sankey.png

Income statement for 2024-07-01 through 2025-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 162,419,000,000 US dollars
- **Cost of products sold**: 156,453,000,000 US dollars
- **Gross margin**: 5,966,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 4,119,000,000 US dollars
- **Operating earnings**: 1,847,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 130,000,000 US dollars
- **Earnings/(loss) before income taxes**: 1,717,000,000 US dollars
- **Provision for income taxes**: 391,000,000 US dollars
- **Net earnings/(loss)**: 1,326,000,000 US dollars
- **UNITED STATES**: 161,247,000,000 US dollars
- **Non-US**: 1,235,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 3,898,000,000 US dollars
- **Restructuring and employee severance**: 61,000,000 US dollars
- **Amortization and other acquisition-related costs**: 331,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 20,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: negative 15,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 176,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 162,482,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 63,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.32 B; to noncontrolling interests: $4.00 M.